The Forms, Challenges and Strength of the Monkeypox Surveillance System in Nigeria
DOI:
https://doi.org/10.30442/ahr.0804-03-178Abstract
Monkeypox is now a disease of global public health concern, making it cut across boundaries into different countries, continents and spread worldwide. However, it originated in the Democratic Republic of Congo as a human pathogen in 1970, with the first case reported in Nigeria in 1971. The World Health Organization recently declared Nigeria the country with the highest burden of monkeypox-confirmed cases and deaths in Africa for the current outbreak. This study aimed to identify forms, challenges, strengths, and ways to further strengthen the surveillance system of monkeypox in Nigeria. We conducted a rapid narrative review of articles published in English on monkeypox between January 2018 and October 2022. Google Scholar and PubMed were searched with the following terms: "Monkeypox", "Surveillance system", "Strengthening", "Challenges" "Nigeria" and relevant publications were reviewed. The forms of surveillance systems in Nigeria include Indicator-based and Event-based surveillance, contact tracing, laboratory-based surveillance, sero-surveillance, and mortality surveillance. Shortage of highly skilled staff in public health interventions, insufficient testing capacities, power instability, poor healthcare systems and stigmatization from communities with misinformation, and co-epidemic surveillance burden in Nigeria are some of the challenges contributing to weak surveillance in the country. The Nigerian governments must focus on investing in surveillance systems and bolster preparedness to stem the rapid spread of infectious diseases. Strengthening the surveillance system in the country as a response intervention for monkeypox is no longer a matter of option in Nigeria but of necessity to prevent the forecasted effect the incidence portends.
References
Eskild P, Ibrahim A, Chikwe I. Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. Int J Infect Dis 2019;78:78-84. https://doi.org/10.1016/j.ijid.2018.11.008
Thornhill J, Barkati S, Walmsley S. Monkeypox virus infection in humans across 16 countries-April-June 2022. N Engl J Med; 2022. https://doi.org/10.1056/NEJMoa2207323
Lateefat K, David I, Gordon I. Trend and enhanced surveillance of Monkeypox during COVID-19 pandemic in Nigeria. J Public Health Afr 2022;13:2184. https://doi.org/10.4081/jphia.2022.2184
Oyewale T. Monkeypox is endemic in Nigeria. But surveillance isn't what it should be. Nigerian Academy of Science. 25 May 2022 10.44 am SAST. https://theconversation.com/monkeypox-is-endemic-in-nigeria-but-surveillance-isnt-what-it-should-be-183711
World Health Organization (WHO) (2020). Global Surveillance for Covid-19 caused by Human Infection with Monkeypox Virus: Interim Guidance: WHO; 2020.
Ibrahim NK. Epidemiologic surveillance for controlling COVID-19 pandemic: types, challenges and implications. J Infect Dis Public Health 2020;13:1630-1638. https://doi.org/10.1016/j.jiph.2020.07.019
Balajee SA, Salyer SJ, Greene-cramer B, Sadek M, Mounts AW. The practice of event-based surveillance: concepts and methods. Glob Secur Health Sci Policy [Internet]. 2021;6:1-9. https://doi.org/10.1080/23779497.2020.1848444
Budd J, Miller BS, Manning EM, Lampos V, Zhuang M, Edelstein M. et al. Digital technologies in the public health response to COVID-19. WHO. Surveillance, case investigation and contact tracing for monkeypox: Interim guidance. 24 June 2022. Nat Med 2020;26:1183–1192. https://doi.org/10.1038/s41591-020-1011-4
WHO. Surveillance, case investigation and contact tracing for monkeypox: Interim guidance. 24 June 2022. https://apps.who.int/iris/handle/10665/357186
Lucero-Prisno DE III, Adebisi YA, Lin X. Current efforts and challenges facing responses to 2019-nCoV in Africa. Glob Health Res Policy 2020;5:148-151. https://doi.org/10.1186/s41256-020-00148-1
Kumar MS, Bhatnagar T, Manickam P, Kumar VS, Rade K, Shah N. et al. National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance. Indian J Med Res 2020; 151:419-423. https://doi.org/10.4103/ijmr.IJMR_1818_20
Milleliri JM, Coulibaly D, Nyobe B, Rey JL, Lamontagne F, Hocqueloux L, et al. SARS-CoV-2 Infection in Ivory Coast: A Serosurveillance Survey among Gold Mine Workers. Am J Trop Med Hyg 2021;104:1709-1712. https://doi.org/10.4269/ajtmh.21-0081
Olayanju O, Bamidele O, Edem F, Eseile B, Amoo A, Nwaokenye J, et al. SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria. Am J Trop Med Hyg. 2021;104:91-94. https://doi.org/10.4269/ajtmh.20-1235
Setel P, AbouZahr C, Atuheire EB, Bratschi M, Cercone E, Chinganya O. et al. Mortality surveillance during the COVID-19 pandemic. Bull World Health Organ 2020;98:374. https://doi.org/10.2471/BLT.20.263194
Ogboghodo EO, Osaigbovo II, Obarisiagbon OO, Okwara BU, Obaseki DE, Omo-Ikirodah OT, et al. Facility-Based Surveillance Activities for COVID-19 Infection and Outcomes among Healthcare Workers in a Nigerian Tertiary Hospital. Am J Trop Med Hyg 2021;104:1034-1040. https://doi.org/10.4269/ajtmh.20-1402
Wolfe CM, Hamblion EL, Dzotsi EK, Mboussou F, Eckerle I, Flahault A. Systematic review of Integrated Disease Surveillance and Response (IDSR) implementation in the African region. PLoS One 2021;16:e0245457. https://doi.org/10.1371/journal.pone.0245457
Adebisi YA, Rabe A, Lucero-Prisno DE III. Risk communication and community engagement strategies for COVID-19 in 13 African countries. Health Promot Perspect 2021;11:137-147. https://doi.org/10.34172/hpp.2021.18
Hassan OB, Nellums LB. Cholera during COVID-19: The forgotten threat for forcibly displaced populations. EClinicalMedicine 2021;32:100753. https://doi.org/10.1016/j.eclinm.2021.100753
Inzaule SC, Tessema SK, Kebede Y, OgwellOuma AE, Nkengasong JN. Genomic-informed pathogen surveillance in Africa: opportunities and challenges. Lancet Infect Dis 2021;21:e281-e289. https://doi.org/10.1016/s1473-3099(20)30939-7
Durski KN, McCollum AM, Nakazawa Y, Petersen BW, Reynolds MG, Briand S. et al. Emergence of Monkeypox — West and Central Africa, 1970–2017. MMWR Morb Mortal Wkly Rep 2018;67:306–310. http://dx.doi.org/10.15585/mmwr.mm6710a5external icon
WHO Director-General's Statement at the press conference of 23 July 2022 following Second IHR Emergency. https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022
Nwokoye M. SciDev.Net. https://www.scidev.net/global/news/africa-must-step-up-surveillance-to-curb-monkeypox/ 2022
Silenou BC, Tom-Aba D, Adeoye O, Arinze CC, Oyiri F, Suleman AK. Use of Surveillance Outbreak Response Management and Analysis System for Human Monkeypox Outbreak, Nigeria, 2017-2019. Emerg Infect Dis 2020;26:345-349. https://doi.org/10.3201/eid2602.191139
NCDC Activates Monkeypox Emergency Operations Centre to Strengthen In-country Preparedness and Contribute to the Global Response. Sunday, 29 May 2022 https://ncdc.gov.ng/themes/common/files/sitreps/fe6bfb6b22289ff41303bcee6a93eefc.pdf
Prevent Epidemics. Covid-19/ Success in Action. Providing fast, flexible funds to shorten the time to respond to disease threats in Nigeria. 16 March 2022. https://preventepidemics.org/stories/funds-to-respond-to-disease-threats-in-nigeria/
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Annals of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The articles and other materials published in the Annals of Health Research are protected by the Nigerian Copyright laws. The journal owns the copyright over every article, scientific and intellectual materials published in it. However, the journal grants all authors, users and researchers access to the materials published in the journal with the permission to copy, use and distribute the materials contained therein only for academic, scientific and non-commercial purposes.
